RTSL
Rapid Therapeutic Science Laboratories, Inc.
Price Chart
Latest Quote
$0.00
+0.00 (+0.00%)
Current Price
| Previous Close | $0.00 |
| Open | $0.00 |
| Day High | $0.01 |
| Day Low | $0.00 |
| Volume | 9,500 |
Stock Information
| Shares Outstanding | 18.99M |
| Total Debt | $3.79M |
| Cash Equivalents | $2K |
| Net Income | $60K |
| Sector | Financial Services |
| Industry | Shell Companies |
| Market Cap | $2K |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.78M |
| Income | $60K |
| Book/sh | $-0.31 |
| Cash/sh | $0.00 |
| Employees | 3 |
Financial Ratios
| Quick Ratio | 0.02 |
| Current Ratio | 0.07 |
Returns & Margins
| ROA | -12.91% |
Ownership
| Institutional Ownership | 7.85% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | -0.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.00 |
| SMA50 | $0.00 |
| SMA200 | $0.00 |
| ATR | 0.0004 |
| Shares Float | 8.14M |
| Volatility | -13.96 |
Performance History
| Week | +0.00% |
| Month | -98.33% |
| Quarter | -98.33% |
| 6 Months | -93.33% |
| YTD | -93.33% |
| Year | -98.65% |
| 3 Years | -99.83% |
| 5 Years | -100.00% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-15 | $0.00 | 0 |
| 2026-06-12 | $0.00 | 0 |
| 2026-06-11 | $0.00 | 0 |
| 2026-06-10 | $0.00 | 0 |
| 2026-06-09 | $0.00 | 0 |
| 2026-06-08 | $0.00 | 0 |
| 2026-06-05 | $0.00 | 0 |
| 2026-06-04 | $0.00 | 0 |
| 2026-06-03 | $0.00 | 0 |
| 2026-06-02 | $0.00 | 0 |
| 2026-06-01 | $0.00 | 0 |
| 2026-05-29 | $0.00 | 0 |
| 2026-05-28 | $0.00 | 1,796 |
| 2026-05-27 | $0.01 | 0 |
| 2026-05-26 | $0.01 | 0 |
| 2026-05-22 | $0.01 | 0 |
| 2026-05-21 | $0.01 | 0 |
| 2026-05-20 | $0.01 | 0 |
| 2026-05-19 | $0.01 | 0 |
| 2026-05-18 | $0.01 | 0 |
About Rapid Therapeutic Science Laboratories, Inc.
Rapid Therapeutic Science Laboratories, Inc. focuses on developing potential commercial opportunities which involve the rapid application of therapeutics using inhaler technology. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in De Leon, Texas.
đ° Latest News
No news articles available at the moment. Check back later for updates on RTSL.
Period:
Loading...
Income Statement (Annual)
| Metric | 2022-12-31 | 2021-12-31 |
|---|---|---|
| Revenue | ||
| Reconciled Cost Of Revenue | $0 | $200 |
| Cost Of Revenue | $0 | $200 |
| Total Revenue | $0 | $534 |
| Operating Revenue | $0 | $534 |
| Expenses | ||
| Interest Expense | $1,895,650 | $1,323,838 |
| Total Expenses | $1,263,333 | $2,176,432 |
| Other Income Expense | $1,364,257 | $631,853 |
| Net Non Operating Interest Income Expense | $-1,895,650 | $-1,323,838 |
| Interest Expense Non Operating | $1,895,650 | $1,323,838 |
| Operating Expense | $1,263,333 | $2,176,232 |
| General And Administrative Expense | $1,239,361 | $2,141,632 |
| Income & Earnings | ||
| Net Income From Continuing Operation Net Minority Interest | $-1,794,726 | $-2,867,883 |
| Net Interest Income | $-1,895,650 | $-1,323,838 |
| Normalized Income | $-3,158,983 | $-3,499,736 |
| Net Income From Continuing And Discontinued Operation | $-1,794,726 | $-2,867,883 |
| Net Income Common Stockholders | $-1,794,726 | $-2,867,883 |
| Net Income | $-1,794,726 | $-2,867,883 |
| Net Income Including Noncontrolling Interests | $-1,794,726 | $-2,867,883 |
| Net Income Continuous Operations | $-1,794,726 | $-2,867,883 |
| Pretax Income | $-1,794,726 | $-2,867,883 |
| Operating Income | $-1,263,333 | $-2,175,898 |
| Depreciation Amortization Depletion Income Statement | $23,972 | $34,600 |
| Depreciation And Amortization In Income Statement | $23,972 | $34,600 |
| Amortization Of Intangibles Income Statement | $0 | $12,500 |
| Depreciation Income Statement | $23,972 | $22,100 |
| Gross Profit | $0 | $334 |
| Per Share | ||
| Diluted EPS | $-0.23 | $-0.38 |
| Basic EPS | $-0.23 | $-0.38 |
| Other | ||
| Tax Effect Of Unusual Items | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-1,239,361 | $-2,141,298 |
| Total Unusual Items | $1,364,257 | $631,853 |
| Total Unusual Items Excluding Goodwill | $1,364,257 | $631,853 |
| Reconciled Depreciation | $23,972 | $34,600 |
| EBITDA (Bullshit earnings) | $124,896 | $-1,509,445 |
| EBIT | $100,924 | $-1,544,045 |
| Diluted Average Shares | $7,746,943 | $7,629,572 |
| Basic Average Shares | $7,746,943 | $7,629,572 |
| Diluted NI Availto Com Stockholders | $-1,794,726 | $-2,867,883 |
| Tax Provision | $0 | $0 |
| Gain On Sale Of Security | $1,364,257 | $631,853 |
| Amortization | $0 | $12,500 |
| Selling General And Administration | $1,239,361 | $2,141,632 |
| Other Gand A | $1,239,361 | $2,141,632 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2022-12-31 | 2021-12-31 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $-3,311,558 | $-1,551,832 |
| Total Assets | $2,254,580 | $2,199,970 |
| Total Non Current Assets | $2,021,387 | $1,780,808 |
| Goodwill And Other Intangible Assets | $170,075 | $170,075 |
| Other Intangible Assets | $170,075 | $170,075 |
| Current Assets | $233,193 | $419,162 |
| Prepaid Assets | $58,146 | $51,631 |
| Inventory | $175,047 | $175,047 |
| Cash Cash Equivalents And Short Term Investments | $0 | $192,484 |
| Cash And Cash Equivalents | $0 | $192,484 |
| Debt | ||
| Net Debt | $3,451,935 | $1,340,950 |
| Total Debt | $3,830,679 | $1,985,467 |
| Long Term Debt And Capital Lease Obligation | $430,235 | $528,744 |
| Long Term Debt | $150,000 | $150,000 |
| Current Debt And Capital Lease Obligation | $3,400,444 | $1,456,723 |
| Current Debt | $3,301,935 | $1,383,434 |
| Other Current Borrowings | - | $1,099,734 |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $5,396,063 | $3,581,727 |
| Total Non Current Liabilities Net Minority Interest | $430,235 | $528,744 |
| Current Liabilities | $4,965,828 | $3,052,983 |
| Other Current Liabilities | $549,240 | $1,085,360 |
| Current Notes Payable | $3,301,935 | $1,383,434 |
| Payables And Accrued Expenses | $1,016,144 | $510,900 |
| Interest Payable | $124,736 | $45,696 |
| Payables | $891,408 | $465,204 |
| Accounts Payable | $891,408 | $465,204 |
| Equity | ||
| Common Stock Equity | $-3,141,483 | $-1,381,757 |
| Total Equity Gross Minority Interest | $-3,141,483 | $-1,381,757 |
| Stockholders Equity | $-3,141,483 | $-1,381,757 |
| Retained Earnings | $-10,316,149 | $-8,521,423 |
| Other | ||
| Ordinary Shares Number | $7,764,594 | $7,742,676 |
| Share Issued | $7,764,594 | $7,742,676 |
| Tangible Book Value | $-3,311,558 | $-1,551,832 |
| Invested Capital | $310,452 | $151,677 |
| Working Capital | $-4,732,635 | $-2,633,821 |
| Capital Lease Obligations | $378,744 | $452,033 |
| Total Capitalization | $-2,991,483 | $-1,231,757 |
| Treasury Stock | $337,339 | $337,339 |
| Additional Paid In Capital | $7,504,242 | $7,469,262 |
| Capital Stock | $7,763 | $7,743 |
| Common Stock | $7,763 | $7,743 |
| Preferred Stock | $0 | $0 |
| Long Term Capital Lease Obligation | $280,235 | $378,744 |
| Current Capital Lease Obligation | $98,509 | $73,289 |
| Current Accrued Expenses | $124,736 | $45,696 |
| Net PPE | $1,851,312 | $1,610,733 |
| Accumulated Depreciation | $-53,327 | $-29,355 |
| Gross PPE | $1,904,639 | $1,640,088 |
| Leases | $342,636 | $427,671 |
| Construction In Progress | $840,591 | $491,005 |
| Other Properties | $721,412 | $721,412 |
| Properties | $0 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2022-12-31 | 2021-12-31 |
|---|---|---|
| Free Cash Flow | ||
| Free Cash Flow | $-1,190,864 | $-2,501,662 |
| Operating Activities | ||
| Operating Cash Flow | $-1,151,709 | $-2,209,131 |
| Cash Flow From Continuing Operating Activities | $-1,151,709 | $-2,209,131 |
| Operating Gains Losses | $-1,364,257 | $-631,853 |
| Investing Activities | ||
| Capital Expenditure | $-39,155 | $-292,531 |
| Investing Cash Flow | $-39,155 | $-292,531 |
| Cash Flow From Continuing Investing Activities | $-39,155 | $-292,531 |
| Financing Activities | ||
| Issuance Of Capital Stock | $0 | $585,000 |
| Financing Cash Flow | $998,380 | $2,195,000 |
| Cash Flow From Continuing Financing Activities | $998,380 | $2,195,000 |
| Net Common Stock Issuance | $0 | $585,000 |
| Common Stock Issuance | $0 | $585,000 |
| Other | ||
| Repayment Of Debt | $-287,900 | $-300,000 |
| Issuance Of Debt | $1,286,280 | $1,910,000 |
| Interest Paid Supplemental Data | $55,619 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 |
| End Cash Position | $0 | $192,484 |
| Beginning Cash Position | $192,484 | $499,146 |
| Changes In Cash | $-192,484 | $-306,662 |
| Net Issuance Payments Of Debt | $998,380 | $1,610,000 |
| Net Short Term Debt Issuance | $998,380 | $-40,000 |
| Short Term Debt Payments | $-287,900 | $-300,000 |
| Short Term Debt Issuance | $1,286,280 | $260,000 |
| Net Long Term Debt Issuance | $0 | $1,650,000 |
| Long Term Debt Issuance | $0 | $1,650,000 |
| Net PPE Purchase And Sale | $-39,155 | $-292,531 |
| Purchase Of PPE | $-39,155 | $-292,531 |
| Change In Working Capital | $200,044 | $88,140 |
| Change In Other Current Assets | $-6,515 | $-39,876 |
| Change In Payables And Accrued Expense | $206,559 | $128,016 |
| Change In Accrued Expense | $79,040 | $24,572 |
| Change In Interest Payable | $79,040 | $24,572 |
| Change In Payable | $127,519 | $103,444 |
| Change In Account Payable | $127,519 | $103,444 |
| Other Non Cash Items | $1,763,258 | $1,147,865 |
| Stock Based Compensation | $20,000 | $20,000 |
| Depreciation Amortization Depletion | $23,972 | $34,600 |
| Depreciation And Amortization | $23,972 | $34,600 |
| Amortization Cash Flow | $0 | $12,500 |
| Amortization Of Intangibles | $0 | $12,500 |
| Depreciation | $23,972 | $22,100 |
| Gain Loss On Investment Securities | $-1,364,257 | $-631,853 |
| Net Income From Continuing Operations | $-1,794,726 | $-2,867,883 |
| Long Term Debt Payments | - | $-300,000 |
| Change In Prepaid Assets | - | $-51,631 |
| Change In Inventory | - | $11,755 |
Fetched: 2026-02-02